Puff Puff Post

MARCH 10, 2020

InMed and CHDR are currently preparing the Clinical Trial Application for a second Phase 1 clinical trial (755-102-HV), planned to begin in the second quarter of 2020, which will examine the local safety of INM-755 on small areas of wounded skin in healthy volunteers. For more information, visit www.inmedpharma.com.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

JULY 28, 2021

The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable Clinical Trials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

DECEMBER 2, 2021

(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials 40

Clinical Trials Data Patients THC 40

Veriheal

JUNE 30, 2023

For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Veriheal

MAY 26, 2022

Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. The ORR, an ongoing online survey study, collects self-reported health information to be analyzed by Johns Hopkins for published research papers.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Greencamp

FEBRUARY 17, 2019

Irritable bowel syndrome (IBS) is a collection of symptoms which create discomfort in the abdominal area, resulting in the inflammation of the digestive tract. We produce endocannabinoids—internal cannabinoid-like compounds, that bind to these cellular endocannabinoid receptors. What is IBS? How to choose the best strain for IBS?

Digestion 96

Digestion Research and Development Marijuana Cannabinoids 96

Cannabis Law Report

FEBRUARY 2, 2022

– Flora’s research division, Flora Pharma, files USPTO provisional patent application on a cannabinoid-based formula. – Flora seeks approval to take their patent-pending, cannabinoid-based product through clinical trials under an EUA from INVIMA (Colombian FDA).

Cannabinoids 40

Cannabinoids Clinical Trials Events Cultivation 40

Cannabis Law Report

NOVEMBER 22, 2021

Emyria was listed on the ASX last year, just before Australia was plunged into the global COVID-19 pandemic, and has been progressing with trials of a synthetic cannabinoid targeting mental health which it hopes to have registered domestically and in the American market.

Clinical Trials 52

Clinical Trials Treatment Medicine Cannabinoids 52

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

MARCH 22, 2020

Aurelius Data, a company dedicated to providing data around plant-based medicines, warned the public Tuesday that THC and COVID-19 don’t mix, based on what they know about how cannabinoids affect patients with influenza. Data CEO Julie Armstrong said her company knows the COVID-19 affects the population in a similar way to influenza.

THC 59

THC Clinical Trials Data Consumption 59

The Cannigma

JULY 1, 2022

Because of this variability in the plant, and because of a lack of standard methods–like chemical analyses of cannabinoids or terpenes–has led to inconsistent scientific results. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.

Research and Development 118

Research and Development Data THC Clinical Trials 118

Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”. About Radicle Science. Radicle Science is a transformative healthtech B-corp offering the first ever path to natural product validation at scale.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

The Joint Blog

FEBRUARY 18, 2020

According to NORML, they reported that the use of medical cannabis, and in particular products dominant in the cannabinoid CBN (cannabinol), was associated with medication-sparing effects. The study is titled Cannabinoid and terpenoid doses are associated with adult ADHD status of medical cannabis patients.

Clinical Trials 45

Clinical Trials Terpenes Data Cannabinoids 45

Otherside Farms

NOVEMBER 3, 2019

The “entourage effect” is the latest buzz in cannabis media, presenting a well-formed scientific hypothesis that cannabinoids don’t just work on their own. They work in tandem with a bunch of other cannabinoids, terpenoids, and flavonoids. It is a non-psychoactive cannabinoid that modulates the effect of psychoactive THC.

Terpenes 58

Terpenes CBD Research and Development Cannabinoids 58

LifeCannMD

JANUARY 31, 2025

As researchers explore new therapeutic frontiers, recent investigations into cannabinoids have sparked interest in the scientific community and among families seeking hope. While discussing cannabinoid therapy with my patients, I often share that we’re not just treating chorea or sleep disturbances we’re preserving moments.

Conditions 52

Conditions Research and Development Cannabinoids Sleep 52

Cannabis Law Report

JULY 4, 2021

Cannabidiol or CBD is one of the most common cannabinoids found in cannabis. Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. There are two different types of cannabinoid receptors in your body. What Is CBD? Where can I buy CBD products in Dublin?

THC 81

THC CBD Legalization Oil 81

Cannabis Law Report

DECEMBER 7, 2021

“Despite the massive and growing market size, there is still scant data on the effectiveness of over-the-counter cannabinoid products due to the cost, speed and scale limitations of the current approach to scientific research,” said Jeff Chen, MD/MBA, Co-founder and CEO of Radicle Science. in less than four days. About Radicle Science.

Clinical Trials 40

Clinical Trials CBD Data Sleep 40

Cannabis Law Report

SEPTEMBER 8, 2021

Products will be distributed through Valens’ Australian Distribution Partner, Cannvalate PTY Ltd (“Cannvalate”), and will be the largest quantity of products provided to Cannvalate for distribution to date (collectively, the “ Transaction “). Schedule 1.

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

SEPTEMBER 3, 2019

(TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty. MediPharm Labs Australia was established in 2017.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

NOVEMBER 7, 2019

With a strong focus on research and development ranging from agronomic research through to clinical trials Cannatrek has an extensive R&D portfolio from Seed to Patient. Cannatrek is actively working on clinical trial protocols with a dedicated focus on mental health.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

NOVEMBER 24, 2021

The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC). Data collection. These were news stories focusing on the use of cannabinoids for chronic cancer pain or inhibiting tumour growth, and mental illness. Discussion.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 10, 2021

An alternative approach to study relationships between marijuana policies and driving after marijuana use is to use surveys that collect information on self-reported behaviors and attitudes. Cannabis Cannabinoid Res. 9-tetrahydrocannabinol on driving performance: a randomized clinical trial. Article Google Scholar.

Policy 45

Policy Safety Marijuana Data 45

Cannabis Law Report

DECEMBER 14, 2021

IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. The trial was conducted as a multiple ascending dose (MAD) study.

Clinical Trials 40

Clinical Trials Safety Data Patients 40

The Cannigma

FEBRUARY 11, 2021

Listen & Subscribe: When Mara Gordon started using medical cannabis there wasn’t any lab testing — or any way to know how much of each cannabinoid or terpene was in a given strain. One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them.

Wellness and Beauty 135

Wellness and Beauty Data Patients Medicine 135

Veriheal

AUGUST 31, 2020

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. About Evan: Evan is an undergraduate student (undecided major) in the College of Liberal Arts at Tufts University. .

Research and Development 119

Research and Development Education Agriculture Patients 119

CannaMD

OCTOBER 7, 2019

While scientists are still searching for a definitive explanation, researchers with Cannabis and Cannabinoid Research have an interesting theory. Analyzing a collection of similar research, Cannabis and Cannabinoid Research summarizes: Across these studies, on average, cannabis users consumed an additional 834?calories/day

Marijuana 107

Marijuana Cannabinoids Patients Conditions 107

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

CannaMD

MARCH 8, 2020

Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. Screening and testing for use of marijuana are encouraged in clinical settings, especially in the care of young patients presenting with cardiovascular disease. More research is needed.

Patients 104

Patients Marijuana Research and Development Clinical Trials 104

The Herb Collective

JUNE 3, 2018

Slows the Progression of Cancer Cells While scientists are still researching CBD oil’s ability to delay the onset of Cancer, clinical trials and American Cancer Society efficacy data suggest that CBD oil combats two conditions associated with cancer cells – oxidative stress and inflammation. There is even CBD Oil for your pets !

Oil 56

Oil CBD Blood Pressure Chronic Pain 56

The Cannigma

MARCH 12, 2021

And he’s looking at it and all these words are coming out, cannabinoids, THC, CBD, ratios, terpenes, and the customer realizes they have no idea what they’re doing. They want also maybe CBD and they want terpenes and they want other cannabinoids in there. and those are intertwined in – they do want THC, but not just THC.

Legalization 132

Legalization Patients Education Dispensary 132

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/ingmargorman/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51